HDAC9 and schizophrenia: Activating DNA demethylation with clozapine and olanzapine with VPA (histone deacetylase inhibitor, HDAC) may be considered a promising therapeutic strategy to normalize GABAergic promoter hypermethylation and decreased GABAergic gene expression detected in postmortem brains of patients with schizophrenia and bipolar disorder